1 Min Read
Nov 21 (Reuters) - Ibio Inc :
* Announces issue of a new Canadian patent in company’s ibiomodulator thermostable immunomodulator protein portfolio Source text for Eikon: Further company coverage:
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2018 Reuters. All Rights Reserved.